Vivek Ramaswamy Quotes
I've said all along that we're building Axovant as a lasting company for the long run, not to hand over that upside to a pharma company in the future.
Topics
Business Strategy
Long Run
Mergers & Acquisitions, M&A, Mergers and Acquisitions
Financial Stability
Company Goals
Company Vision
Corporate Growth
Future Plans
Long-Term Investment
Long-Term Strategy
Shareholder Value
Strategic Partnership
Sustainable Business Model
Value Creation
Pharma Industry
Citations
Vardi, Nathan. "Boy In The Bubble: How Vivek Ramaswamy Spun A 'Junk' Drug Into A $3 Billion Biotech." Forbes, 11 Apr. 2016.
Related Quotes
Vivek Ramaswamy is an American entrepreneur in the biotechnology sector. He is the founder and executive chairman of the biopharmaceutical company Roivant Sciences. Prior to founding Roivant in 2014, Ramaswamy co-founded a technology company and was a partner at an investment firm. He is a graduate of Harvard College and Yale Law School and has written about the undue influence of corporate power on American democracy.